AUSTIN, TEXAS / ACCESS Newswire / April 3, 2025 / The Piazza Center proudly announces that board-certified plastic surgeon Dr. Rocco Piazza has been selected as one of the few elite plastic surgeons ...

GERMANTOWN, TENNESSEE / ACCESS Newswire / April 3, 2025 / Travel Nurses, Inc. entered a partnership with Souled Outside ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 3, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and researching life-saving medicines in a variety of ...

ORLANDO, FLORIDA / ACCESS Newswire / April 3, 2025 / MARIJUANA INC. (OTC PINK:MAJI), dba Exousia Pro, Inc., a clinical-stage biotech company utilizing exosomes in the treatment of cancer and other ...

The global fecal calprotectin test market is on a trajectory of substantial growth, with projections estimating an increase ...

The Pistoia Alliance, a global, not-for-profit alliance that advocates for greater collaboration in life sciences R&D, has released new findings on data-driven innovation and AI in life sciences in ...

Honeywell (NASDAQ: HON) today introduced TrackWise Manufacturing, an artificial intelligence (AI)-assisted, cloud-native platform designed to transform how life sciences companies manage, automate and ...

Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, today announces a positive opinion from the European Medicines Agency (EMA)’s Committee for ...

Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome.

Birmingham scientists have shown that a sequence of just three amino acids may reduce the severity of psoriasis, when applied topically in an emollient cream. The researchers, whose study is published ...

Akiram Therapeutics, a Swedish biotech company specializing in targeted radiotherapy, today announces the launch of PRE-CISE, a Eurostars-funded research collaboration with Danish PreTT and TetraKit ...

Hansa Biopharma, “Hansa” (Nasdaq Stockholm: HNSA), will publish its interim report for January - March 2025 on 24 April, 2025. Interested parties may join the Company’s quarterly conference call on ...